Compare CABA & INBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CABA | INBK |
|---|---|---|
| Founded | 2017 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.7M | 181.7M |
| IPO Year | 2019 | N/A |
| Metric | CABA | INBK |
|---|---|---|
| Price | $2.16 | $21.09 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | $14.57 | ★ $28.67 |
| AVG Volume (30 Days) | ★ 1.8M | 55.0K |
| Earning Date | 11-10-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 1.14% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $46,731,000.00 |
| Revenue This Year | N/A | $4.47 |
| Revenue Next Year | N/A | $25.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.99 | $17.05 |
| 52 Week High | $3.67 | $36.72 |
| Indicator | CABA | INBK |
|---|---|---|
| Relative Strength Index (RSI) | 44.96 | 52.97 |
| Support Level | $2.08 | $20.18 |
| Resistance Level | $2.25 | $22.01 |
| Average True Range (ATR) | 0.13 | 0.81 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 40.79 | 55.83 |
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.